文献速递神经外科与老年麻醉

星状神经节阻滞对中重度创伤性脑损伤脑血流动力学及炎症反应的影响:一项初步研究

Effect of stellate ganglion block on brain hemodynamics and the inflammatory response in moderate and severe traumatic brain injury: a pilot study.
PubMed 文献 · Reg Anesth Pain Med · 2026-06-05

这项前瞻性单中心观察性初步研究纳入20例中重度创伤性脑损伤(TBI)患者,在C6水平超声引导下经侧入路对受损最严重半球同侧行星状神经节阻滞(SGB),注射8 mL 0.5%左布比卡因。结果显示SGB显著降低同侧大脑中动脉血流速度、增加脑底大动脉直径、改善部分区域脑血流与容量,IL-6和S100B在24小时内显著下降,颅内压降低、脑灌注压与脑组织氧供改善,未见不良事件。

要点

  • SGB可降低TBI患者颅内压并改善脑灌注压与脑组织氧供。
  • SGB后24小时内IL-6和S100B显著下降,提示可能调节神经炎症。
  • SGB降低同侧大脑中动脉血流速度并增加脑底大动脉直径。

核心结论

  • SGB可调节TBI患者脑血流动力学并降低颅内压,显示作为神经保护干预的潜力。
  • 仍需进一步随机对照试验确定SGB在TBI治疗中的最佳应用及短期和长期获益。

研究设计与样本

  • 前瞻性、单中心观察性初步研究,纳入20例中重度TBI患者。
  • SGB在C6水平超声引导下经侧入路、于受损最严重半球同侧实施,注射8 mL 0.5%左布比卡因。
  • 主要结局为经颅彩色编码双功超声测量的同侧大脑中动脉血流速度在操作前后的变化。

主要发现

  • SGB显著降低大脑中动脉血流速度,并增加脑底大动脉直径。
  • SGB改善同侧部分脑区的脑血流量和脑血容量。
  • IL-6和S100B在SGB后24小时内显著下降。
  • SGB后颅内压降低,脑灌注压和脑组织氧供改善。
  • 未观察到不良事件。

关键数值与推荐

  • 主要结局为同侧大脑中动脉血流速度变化,采用经颅彩色编码双功超声测量。
  • 次要结局包括经CT血管成像测量的脑底动脉直径、经CT灌注成像测量的脑血流量/容量/达峰时间,以及脑灌注压、颅内压和脑氧合。
  • 三级结局为基线、SGB后12小时和24小时测量的IL-6、神经元特异性烯醇化酶、S100B和胶质纤维酸性蛋白。

临床怎么用

  • 对中重度TBI患者,可考虑在受损最严重半球同侧C6水平超声引导下行SGB以改善脑血流动力学和降低颅内压。
  • SGB后应监测颅内压、脑灌注压及脑氧合变化,并可在24小时内复查IL-6和S100B等炎症与脑损伤标志物。

局限性

  • 本研究为单中心观察性初步研究,样本量20例,无对照组。
  • SGB对TBI的最佳应用及短期和长期获益尚需随机对照试验确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Traumatic brain injury (TBI) is often associated with reduced cerebral blood flow and an increased inflammatory response, leading to secondary brain damage. Stellate ganglion block (SGB) has been shown to improve cerebral hemodynamics in non-TBI, but its effects in TBI are still unclear. OBJECTIVE: This prospective pilot study investigates the effects of SGB on cerebral hemodynamics and neuroinflammatory responses in patients with moderate to severe TBI with the aim of evaluating its potential as a therapeutic intervention. METHODS: A prospective, single-center observational study was conducted in 20 patients with moderate to severe TBI. SGB was performed ipsilateral to the most severely affected hemisphere using an ultrasound-guided lateral approach at the level of C6 with 8 mL 0.5% levobupivacaine. The primary outcome was the change in blood flow velocity in the ipsilateral middle cerebral artery as measured by transcranial color-coded duplex ultrasonography before and after the procedure. Secondary outcomes included changes in (a) the diameter of the basal arteries of the brain as measured by computed angiography tomography; (b) cerebral blood flow, volume and time to peak as measured by computed perfusion tomography; (c) cerebral perfusion pressure, intracranial pressure and brain oxygenation. The changes in the biomarkers of inflammation and brain injury interleukin 6, neuron-specific enolase, protein S100B and glial fibrillar acidic protein measured at baseline, 12 hours and 24 hours after SGB were defined as tertiary outcomes. RESULTS: SGB significantly reduced blood flow velocity in the middle cerebral artery, increased the diameter of the large basal cerebral arteries, improved cerebral blood flow and volume in certain brain regions on the ipsilateral side. Inflammatory markers such as IL-6 and S100B decreased significantly within 24 hours. The intracranial pressure decreased, the cerebral perfusion pressure and the oxygen supply to the brain tissue improved after SGB. No adverse events were observed. CONCLUSION: SGB modulates cerebral hemodynamics and lowers intracranial pressure in patients with TBI, demonstrating its potential as a neuroprotective intervention. While these results highlight the therapeutic potential of SGB, further randomized controlled trials are needed to determine its optimal use and short-term and long-term benefits in the treatment of TBI. TRIAL REGISTRATION NUMBER: NCT04208477.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Kostadinov I, Avsenik J, Osredkar J, et al. Effect of stellate ganglion block on brain hemodynamics and the inflammatory response in moderate and severe traumatic brain injury: a pilot study. Reg Anesth Pain Med. 2026. PMID: 39971387. doi:10.1136/rapm-2024-106185

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。